Bio-Resonant Restoration - Epigenetic Memory Reactivation via Piezoelectric Resonance: A Mechanistic Framework for Cellular Restoration

Abstract

Cellular aging and pathogen-induced damage represent fundamental challenges in regenerative medicine. Current therapeutic approaches rely predominantly on chemical interventions that generate systemic side effects and fail to address the underlying loss of cellular homeostatic memory. We present a mechanistic framework proposing that cells retain epigenetic memory of their healthy equilibrium state, and that targeted acoustic resonance can reactivate this memory through piezoelectric signal transduction. This framework comprises two distinct operational modes: (1) constructive resonance for cellular restoration via entrainment-based epigenetic reactivation, and (2) destructive resonance for selective pathogen elimination via acoustic cavitation-induced membrane disruption. Both modes leverage established principles from epigenetic reprogramming, piezoelectric biomaterials, and acoustic impedance physics. We provide testable experimental protocols and identify specific parameters requiring empirical characterization. This framework offers a research pathway for developing non-pharmacological cellular restoration therapies with potential applications in aging reversal, neurodegenerative disease, oncology, and infectious disease treatment.

Dependencies

https://github.com/limabravoecho-collab/unified-attractor-complexity-model

https://github.com/limabravoecho-collab/unified-attractor-complexity-model-how-and-why-A-Dual-Framework-Cosmology

https://github.com/limabravoecho-collab/Bio-Resonant-Restoration-A-Mechanistic-Framework-for-Cellular-Restoration

Keywords: Epigenetic memory, piezoelectric stimulation, acoustic resonance, cellular restoration, partial reprogramming, acoustic cavitation, pathogen elimination

---

1. Introduction

1.1 The Challenge of Cellular Restoration

Cellular decay—whether from aging, disease, or pathogenic invasion—has historically been treated as an irreversible progression requiring external intervention. Conventional pharmacological approaches target downstream symptoms rather than addressing the fundamental loss of cellular homeostatic function. Recent advances in epigenetic reprogramming have demonstrated that aged cells retain memory of their youthful state, with partial reprogramming using OSK factors capable of reversing age-related deterioration while preserving cell identity. However, genetic manipulation approaches face significant challenges including teratoma risk, inefficient delivery, and difficulty controlling expression timing.

Simultaneously, the field of piezoelectric biomaterials has established that mechanical forces can be converted into electrical signals that modulate bone microenvironments and promote tissue regeneration. These converging insights suggest an unexplored therapeutic pathway: leveraging acoustic resonance to reactivate cellular memory through piezoelectric transduction, bypassing the need for genetic manipulation.

1.2 Current Friction Points in the Field

Three conceptual constraints have prevented integration of these principles:

The Chemical-Exclusivity Bias: The assumption that cellular function can only be modulated through molecular concentrations, neglecting the role of bioelectrical signaling in cellular behavior.

The Static-State Assumption: The belief that cells exist only in their current epigenetic configuration, ignoring the demonstrated persistence of homeostatic "memory" even in aged or damaged cells.

The Destructive-Uniformity Fallacy: The approach that pathogen neutralization requires broad-spectrum cytotoxicity rather than targeted mechanical disruption based on structural resonance.

1.3 Proposed Framework

We propose that cellular restoration and pathogen elimination can be achieved through two distinct acoustic resonance protocols:

Mode 1 - Cellular Restoration (Constructive Resonance): Reactivation of epigenetic memory in aged/damaged cells through piezoelectric signal amplification, enabling cells to return to homeostatic equilibrium without genetic manipulation.

Mode 2 - Pathogen Elimination (Destructive Resonance): Selective mechanical disruption of pathogenic cells through acoustic cavitation targeting structural impedance mismatches, leaving healthy cells intact.

This framework builds exclusively on established scientific principles—no new physics or biology is proposed. Rather, we integrate existing knowledge from epigenetics, piezoelectricity, and acoustic physics into a unified therapeutic strategy.

---

2. Theoretical Foundation

2.1 Epigenetic Memory and Cellular Homeostasis

2.1.1 Epigenetic Memory Retention

OSK-mediated epigenetic reprogramming substantially reverses senescence-associated pathology and transcriptomic changes, demonstrating that senescent cells retain accessible memory of younger states. This phenomenon indicates cells maintain a "backup copy" of their homeostatic configuration through persistent chromatin markings, even as they drift toward aged or diseased states.

Targeted partial reprogramming of age-associated cell states in mouse models improved markers of health without inducing pluripotency, confirming that cellular memory restoration can occur without complete dedifferentiation. The mechanism operates through chromatin remodeling that restores gene expression patterns characteristic of younger cells while preserving cell identity through retention of somatic enhancer methylation.

2.1.2 The Epigenetic Maintenance Threshold

Not all cells can be restored. We define the Epigenetic Maintenance Threshold as the minimum chromatin state integrity required to preserve cellular identity and enable restoration to homeostatic equilibrium. Below this threshold, methylation pattern fidelity and histone modification maintenance degrade, preventing memory-based repair. This threshold represents a critical boundary for therapeutic intervention: cells above this threshold can be restored; those below require replacement through regenerative approaches.

2.2 Piezoelectric Signal Transduction in Biological Systems

2.2.1 Endogenous Piezoelectricity

Piezoelectric collagen fibers are present in cartilage and bone, acting as mechanoelectrical transducers that generate electric fields in response to minute mechanical vibrations. This endogenous piezoelectricity plays a functional role in tissue maintenance: when mechanical forces are exerted on collagen fibrils, they generate electrical signals that modulate cellular behavior through voltage-gated ion channels.

The piezoelectric effect in biological tissue operates through a well-characterized pathway: mechanical stress → dipole alignment → charge generation → membrane potential modulation → intracellular signaling cascade activation. This natural mechanism can be amplified through external acoustic stimulation.

2.2.2 Piezoelectric Biomaterials for Cellular Modulation

Piezoelectric biomaterials offer a distinct advantage by enabling sustained and targeted electrical stimulation for tissue regeneration, eliminating reliance on growth factors or therapeutic molecules. Recent advances demonstrate that piezoelectric parameters can be engineered to guide bone regeneration at the cellular level, including cell adhesion, proliferation, and osteogenic differentiation.

Critical to therapeutic application, piezoelectric scaffolds can simulate the physiological microelectrical environment of tissues to facilitate regeneration and promote repair of defects. This principle extends beyond structural tissues: electrical stimulation modulates cellular behavior across diverse cell types by affecting intracellular signaling pathways including Wnt/β-catenin and PI3K/Akt.

2.3 Acoustic Impedance and Selective Membrane Disruption

2.3.1 Acoustic Cavitation Mechanisms

Ultrasound inactivates bacteria and deagglomerates bacterial clusters through physical, mechanical, and chemical effects arising from acoustic cavitation. The process operates through bubble formation and collapse: acoustic cavitation of microbubbles generates submicron pores in cell membranes through local membrane rupture from bubble collapse or compression.

Critically, flow cytometry results indicate high sensitivity to 20 and 40 kHz frequency with continuous decrease in viable bacterial cells, while higher frequency of 580 kHz predominantly causes deagglomeration rather than cell membrane disruption. This frequency-dependent selectivity provides a mechanism for controlled therapeutic application.

2.3.2 Acoustic Impedance Mismatch

Cell membrane disruption through acoustic cavitation relies on impedance mismatch between cellular structures. The impact of bubble collapse on membrane permeation decreases rapidly with increasing distance between bubble and cell membrane, with effective range determined to be distance/diameter = 0.75. This spatial dependence enables targeting specificity.

Different cell types exhibit distinct acoustic impedance profiles due to variations in lipid composition, cytoskeletal architecture, and membrane protein content. Malignant cells typically display altered membrane properties compared to healthy cells, creating differential susceptibility to acoustic cavitation—a principle that can be exploited for selective disruption.

---

3. Mechanistic Framework

3.A. Mode 1: Cellular Restoration via Constructive Resonance

3.A.1 Core Principle

Aged or damaged cells have not lost their homeostatic memory—they have lost the signal-to-noise ratio required to express it. By providing targeted piezoelectric stimulation at specific frequencies, we hypothesize that cells can be "re-tuned" to their stored equilibrium template through a process analogous to Huygens' entrainment principle.

3.A.2 Operational Mechanism

Step 1: Acoustic Signal Generation
Piezoelectric transducers generate mechanical vibrations at frequencies corresponding to the target cell's homeostatic resonance profile (empirically determined through impedance spectroscopy).

Step 2: Piezoelectric Transduction
Endogenous collagen and other piezoelectric structures within cells convert mechanical vibrations into electrical signals, modulating membrane potential and activating voltage-gated ion channels.

Step 3: Intracellular Cascade Activation
Electrical signals trigger established signaling pathways (Ca²⁺/calmodulin, Wnt/β-catenin, PI3K/Akt) that regulate chromatin remodeling enzymes and transcription factors.

Step 4: Epigenetic Reactivation
Chromatin remodeling initiated by these signals accesses the cell's preserved homeostatic memory, similar to early events evoked by OSK factors during partial reprogramming.

Step 5: Homeostatic Restoration
Cells progressively return to their equilibrium state as gene expression patterns characteristic of younger cells are restored while somatic enhancer methylation preserves cell identity.

3.A.3 Key Parameters Requiring Empirical Characterization

1. Frequency Signature Profiles: Cell-type-specific resonance frequencies that maximize piezoelectric response
2. Amplitude Thresholds: Minimum mechanical displacement required to initiate cascade without causing damage
3. Exposure Duration: Optimal stimulation periods for different cell types and damage severities
4. Pulse Patterns: Continuous vs. intermittent stimulation protocols
5. Multi-frequency Combinations: Whether simultaneous frequencies enhance restoration efficiency

3.A.4 Proposed Experimental Validation

Phase 1 - In Vitro Cell Line Studies:

• Culture aged human fibroblasts and senescent cells
• Characterize acoustic impedance profiles across cell age states
• Apply candidate frequency ranges via piezoelectric substrate
• Measure epigenetic age reversal using DNA methylation clocks
• Assess functional restoration through metabolic activity, proliferation capacity, and stress resistance

Phase 2 - Mechanism Elucidation:

• Monitor real-time intracellular calcium dynamics during stimulation
• Track chromatin accessibility changes via ATAC-seq
• Identify activated signaling pathways through phosphoproteomics
• Confirm epigenetic memory access through histone modification profiling

Phase 3 - Tissue-Level Validation:

• Test in 3D organoid models representing specific tissues
• Assess restoration homogeneity across cell populations
• Validate absence of dedifferentiation through lineage marker expression
• Evaluate long-term stability of restored state post-treatment

3.B. Mode 2: Pathogen Elimination via Destructive Resonance

3.B.1 Core Principle

Pathogenic cells and malignant cells exhibit distinct acoustic impedance profiles compared to healthy cells due to altered membrane composition and structural properties. By identifying resonance frequencies that induce acoustic cavitation in target cells while remaining below the cavitation threshold for healthy cells, selective mechanical disruption can be achieved.

3.B.2 Operational Mechanism

Step 1: Target Impedance Characterization
Measure acoustic impedance profiles of pathogenic/malignant cells and adjacent healthy tissue using broadband acoustic spectroscopy. Identify frequency windows where impedance differential is maximized.

Step 2: Cavitation Threshold Determination
Determine the acoustic pressure amplitude required to induce cavitation at specific frequencies for both target and healthy cells. Establish therapeutic window where target cells undergo disruption while healthy cells remain intact.

Step 3: Targeted Acoustic Delivery
Apply focused ultrasound at calculated frequency and amplitude to affected tissue region. Treatment duration and power adjusted based on target cell density and tissue penetration depth.

Step 4: Cavitation-Induced Disruption
Acoustic waves generate cavitation—formation and collapse of vapor bubbles—releasing energy during bubble implosion that generates intense shear forces disrupting cell membranes.

Step 5: Selective Lysis
Target cells with matched impedance profiles undergo membrane rupture and lysis. The spatial range of cavitation impact ensures localized effect on cells in immediate proximity to cavitation events, minimizing collateral damage.

3.B.3 Key Parameters Requiring Empirical Characterization

1. Target-Specific Resonance Frequencies: Frequency ranges that maximize cavitation in pathogen/malignant cells
2. Selectivity Windows: Minimum impedance differential required for safe therapeutic application
3. Cavitation Monitoring: Real-time feedback systems using broadband noise measurements to correlate cavitation activity with cellular effects
4. Tissue Penetration: Frequency-dependent attenuation in different tissue types
5. Multi-Pass Protocols: Sequential treatment strategies for layered pathogen elimination

3.B.4 Proposed Experimental Validation

Phase 1 - In Vitro Selectivity Studies:

• Co-culture pathogenic bacteria/cancer cells with healthy cell lines
• Characterize differential acoustic impedance profiles
• Apply candidate frequency ranges with varying amplitudes
• Measure selective lysis using flow cytometry viability assays
• Quantify collateral damage to healthy cells

Phase 2 - Cavitation Dynamics:

• Employ high-speed imaging to visualize bubble formation and collapse
• Correlate cavitation dose (time integral of broadband noise) with cell disruption efficiency
• Map spatial distribution of cavitation events relative to cell positions
• Optimize pulse parameters to maximize selectivity

Phase 3 - Tissue-Level Validation:

• Test in infected tissue models or tumor spheroids
• Assess penetration depth and effective treatment volume
• Validate absence of inflammatory response beyond target region
• Evaluate clearance efficiency compared to standard antimicrobial/anticancer therapies

---

4. Safety Architecture and Regulatory Considerations

4.1 Biological Safety Constraints

Both operational modes require strict safety envelopes to prevent unintended cellular damage:

4.1.1 Thermal Safety Limits

Acoustic energy generates heat through tissue absorption. Maximum power density must remain below tissue-specific thermal damage thresholds (~43°C sustained temperature).

4.1.2 Mechanical Safety Limits

Acoustic pressure must be controlled to ensure cavitation occurs only in target cells, with healthy tissue exposure remaining below cavitation threshold by minimum 20% safety margin.

4.1.3 Temporal Safety Limits

Exposure duration must be limited based on tissue perfusion capacity, preventing accumulation of mechanical stress or metabolic disruption.

4.1.4 Selectivity Safety Limits

For Mode 2 (elimination), acoustic impedance differential between target and healthy cells must exceed 15% to ensure therapeutic window. Below this threshold, treatment should be aborted.

4.2 Real-Time Monitoring and Feedback Systems

Epigenetic State Monitoring (Mode 1):
Continuous assessment of DNA methylation patterns at key age-associated CpG sites using rapid bisulfite-free sequencing methods. Treatment terminates when target methylation profile is achieved.

Cavitation Activity Monitoring (Mode 2):
Broadband noise detection via calibrated hydrophone arrays provides real-time quantification of cavitation dose. Automated feedback adjusts acoustic parameters or terminates treatment if collateral damage indicators appear.

Viability Monitoring (Both Modes):
Adjacent healthy tissue assessed for membrane integrity using impedance spectroscopy or fluorescent viability markers. Treatment halts if healthy cell damage exceeds 2% threshold.

4.3 Regulatory Pathway Considerations

This framework proposes non-pharmacological interventions falling under medical device regulation rather than drug approval pathways:

Mode 1 (Restoration): Would require demonstration of:

• Absence of tumorigenic potential over long-term follow-up
• Preserved cellular identity and function post-treatment
• Dose-response characterization for different tissue types
• Minimal systemic effects beyond treated region

Mode 2 (Elimination): Would require demonstration of:

• Selectivity ratios exceeding established standards (>100:1 target:healthy)
• Clearance efficiency comparable to or exceeding current standards
• Absence of resistance development in pathogenic targets
• Minimal inflammatory response and tissue damage

Both modes would benefit from staged clinical development:

1. Ex vivo validation using patient-derived samples
2. Phase I safety studies in limited tissue volumes
3. Phase II efficacy studies with surrogate endpoints
4. Phase III comparative effectiveness trials

---

5. Discussion

5.1 Integration with Existing Therapeutic Paradigms

This framework does not replace existing therapies but offers complementary approaches:

Synergy with Partial Reprogramming:
Chemical reprogramming cocktails partially reprogram cells but face challenges with efficiency and safety. Acoustic stimulation could enhance chemical reprogramming efficiency by providing the bioelectrical component of cellular reactivation, potentially reducing required chemical exposure.

Augmentation of Antimicrobial Therapy:
Acoustic cavitation could enhance antibiotic penetration into bacterial biofilms while directly disrupting resistant strains, offering combination therapy advantages.

Precision Oncology Applications:
Tumor-specific acoustic signatures could enable targeted destruction without systemic chemotherapy toxicity, particularly valuable for surgically inaccessible tumors or minimal residual disease.

5.2 Limitations and Open Questions

Frequency Discovery Challenge:
The framework provides the method but not the specific frequencies. Comprehensive mapping of cell-type-specific acoustic impedance profiles represents a substantial empirical undertaking requiring:

• High-throughput impedance spectroscopy platforms
• Machine learning models to predict resonance from structural parameters
• Validation across genetic backgrounds and disease states

Tissue Heterogeneity:
In vivo tissues contain multiple cell types with overlapping impedance profiles. Achieving therapeutic selectivity in complex tissue environments may require:

• Multi-frequency protocols targeting combinations of impedance characteristics
• Spatial targeting using focused ultrasound to restrict treatment volume
• Pre-treatment impedance mapping using diagnostic acoustic imaging

Epigenetic Stability Post-Treatment:
Restored epigenetic states must be maintained after treatment withdrawal. Long-term stability may require:

• Periodic "maintenance" stimulation to prevent drift
• Combination with environmental modifications supporting homeostasis
• Development of biomarkers predicting risk of reversion

Cavitation Control Precision:
Cavitation impact range decreases rapidly with distance, but spatial precision requirements for in vivo application remain undefined. Research needed on:

• Focused ultrasound targeting resolution limits
• Cavitation nuclei (microbubbles) to enhance spatial confinement
• Real-time adaptive adjustment of acoustic parameters

5.3 Comparative Advantages

Versus Genetic Reprogramming:

• No viral vectors or gene editing required (eliminates insertional mutagenesis risk)
• Reversible and titratable intervention
• Can be applied periodically without accumulating genetic load

Versus Chemical Therapies:

• Localized effect minimizes systemic toxicity
• Cell-type selectivity based on physical properties rather than receptor expression
• Reduced risk of resistance development (physical vs. biochemical mechanism)

Versus Surgical/Ablative Approaches:

• Non-invasive or minimally invasive delivery
• Preserves tissue architecture
• Applicable to distributed disease (e.g., metastases, systemic aging)

5.4 Broader Implications

If validated, this framework suggests a paradigm shift in regenerative and antimicrobial medicine:

From Chemical to Physical Medicine:
Recognition that cellular behavior can be modulated through bioelectrical signals opens therapeutic avenues beyond molecular targeting, potentially applicable to numerous age-related and infectious diseases.

From Replacement to Restoration:
Rather than replacing damaged cells or organs, restoration of existing cells to functional states could reduce dependence on transplantation and stem cell therapies.

From Universal to Personalized Frequencies:
Individual variation in acoustic impedance profiles suggests personalized frequency prescriptions may optimize therapeutic outcomes, paralleling the precision medicine movement.

5.5 Immediate Research Priorities

To advance this framework toward clinical application, the field requires:

1. Standardized Impedance Characterization:

   • Establishment of reference databases for cell-type-specific acoustic properties
   • Development of rapid diagnostic tools for patient-specific impedance profiling
   • Validation of impedance as a stable biomarker across experimental conditions

2. Computational Modeling:

   • Multi-scale models predicting acoustic wave propagation in complex tissue
   • Machine learning algorithms identifying optimal frequency combinations
   • Simulation platforms for treatment planning and dose optimization

3. Clinical Translation Infrastructure:

   • Development of clinical-grade piezoelectric stimulation devices
   • Integration with existing ultrasound imaging platforms for real-time guidance
   • Establishment of Good Manufacturing Practice for frequency "prescription" protocols

4. Biomarker Development:

   • Identification of early indicators of successful epigenetic reactivation
   • Non-invasive monitoring methods for treatment response assessment
   • Predictive markers of patients most likely to respond

---

6. Conclusion

We have presented a mechanistic framework proposing that cellular restoration and selective pathogen elimination can be achieved through targeted acoustic resonance, leveraging cells' retained homeostatic memory and differential acoustic impedance properties. This framework integrates established principles from epigenetic reprogramming, piezoelectric biomaterials, and acoustic cavitation physics without invoking new biological or physical mechanisms.

The framework comprises two operationally distinct modes:

• Mode 1 (Constructive Resonance): Reactivates epigenetic memory in aged/damaged cells through piezoelectric signal amplification
• Mode 2 (Destructive Resonance): Selectively disrupts pathogenic/malignant cells through acoustic cavitation

Both modes require extensive empirical characterization of frequency parameters, safety limits, and optimal treatment protocols. We have identified specific experimental validation pathways and acknowledged key limitations requiring resolution before clinical translation.

This work does not claim to provide a complete therapeutic solution but offers a research direction that, if validated, could complement existing therapies and address current limitations in regenerative and antimicrobial medicine. The framework provides sufficient mechanistic detail and testable predictions to enable immediate experimental investigation by research groups with expertise in cellular reprogramming, biomaterials, and acoustic physics.

Future work should focus on high-throughput frequency characterization, computational modeling of acoustic-cellular interactions, and systematic safety evaluation in increasingly complex model systems. Success in these areas would establish whether acoustic resonance represents a viable therapeutic modality for cellular restoration and selective pathogen elimination.

---

References

1. Paine, C. J., et al. (2024). Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology. Aging Cell, 23(2), e14039.

2. Yang, J. H., et al. (2023). Chemically induced reprogramming to reverse cellular aging. Aging, 15(13), 5966-5988.

3. Sahu, S. K., et al. (2024). Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging. Science Translational Medicine, 16(736), eadg1777.

4. Tyshkovskiy, A., et al. (2024). The long and winding road of reprogramming-induced rejuvenation. Nature Communications, 15, 2143.

5. Lucas, D., & Paine, C. J. (2024). Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation. eLife, 13, e90579.

6. Gill, D., et al. (2022). Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. eLife, 11, e71624.

7. Macip, C. C., et al. (2024). Gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice. Cellular Reprogramming, 26(1), 17-32.

8. Ni, Z., et al. (2025). Piezoelectric biomaterials for bone regeneration: Roadmap from dipole to osteogenesis. Advanced Science, 12(8), e2414969.

9. Singh, P., et al. (2018). Piezoelectric smart biomaterials for bone and cartilage tissue engineering. Inflammation and Regeneration, 38, 2.

10. Wang, X., et al. (2024). From electricity to vitality: the emerging use of piezoelectric materials in tissue regeneration. Burns & Trauma, 12, tkae013.

11. Nain, A., et al. (2024). Progress in the development of piezoelectric biomaterials for tissue remodeling. Biomaterials, 307, 122528.

12. Tan, Y., et al. (2024). Advances in self-powered biomaterials for bone defect repair. Advanced Composites and Hybrid Materials, 8, 26.

13. Joyce, E., et al. (2003). Ultrasonic enhancement of cold water detergency. Journal of Applied Microbiology, 94(3), 735-746.

14. Fan, C. H., et al. (2012). Controlled permeation of cell membrane by single bubble acoustic cavitation. Journal of Controlled Release, 157(1), 103-111.

15. Mason, T. J., et al. (2011). Assessing the effect of different ultrasonic frequencies on bacterial viability using flow cytometry. Journal of Applied Microbiology, 110(4), 862-870.

16. Qian, Z., et al. (2006). ULTRASOUND INCREASES THE RATE OF BACTERIAL CELL GROWTH. Biotechnology Progress, 12(5), 638-644.

17. Vorontsov, E., et al. (2021). Bacterial cell inactivation using a single-frequency batch-type ultrasound device. Journal of Food Process Engineering, 44(4), e13646.

18. McNamara, A. J., et al. (2006). Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound in Medicine & Biology, 32(7), 1111-1122.

19. Abcam. (2024). Cell lysis techniques: Methods and applications. Retrieved from https://www.abcam.com/en-us/knowledge-center/cell-biology/cell-lysis

---

Acknowledgments

This work represents a synthesis of established principles across multiple disciplines. We acknowledge the extensive research communities in epigenetics, biomaterials science, and acoustic physics whose foundational work enabled this integrative framework.

Competing Interests

The authors declare no competing financial interests.

Author Contributions

Conceptual framework development, literature synthesis, and manuscript preparation.

---

Supplementary Materials

Supplementary Table 1: Proposed Frequency Characterization Protocol

Cell Type	Impedance Range (Preliminary)	Proposed Frequency Scan Range	Priority Level
Human Fibroblasts (Young)	TBD	100 Hz - 10 MHz	High
Human Fibroblasts (Aged)	TBD	100 Hz - 10 MHz	High
Neuronal Cells	TBD	1 kHz - 5 MHz	High
Cardiomyocytes	TBD	100 Hz - 1 MHz	Medium
E. coli (Target)	TBD	20 kHz - 100 kHz	High
S. aureus (Target)	TBD	20 kHz - 100 kHz	High
Cancer Cell Lines	TBD	100 Hz - 10 MHz	High

Supplementary Table 2: Safety Parameter Ranges

Parameter	Mode 1 (Restoration)	Mode 2 (Elimination)	Monitoring Method
Acoustic Pressure	< 0.5 MPa	0.5 - 2.0 MPa	Calibrated hydrophone
Temperature Increase	< 2°C	< 5°C	Thermal imaging
Exposure Duration	1-60 min	10 sec - 5 min	Treatment timer
Collateral Damage Threshold	< 0.5%	< 2%	Flow cytometry viability
Epigenetic Drift (Mode 1)	< 5% from target	N/A	Methylation sequencing

---

This manuscript presents a theoretical framework requiring extensive experimental validation. All claims should be considered hypotheses pending empirical confirmation.